Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Inogen (INGN) News Today

$8.77
-0.06 (-0.68%)
(As of 10:15 AM ET)
Jason Somer Sells 10,000 Shares of Inogen, Inc. (NASDAQ:INGN) Stock
Inogen, Inc. (NASDAQ:INGN - Get Free Report) EVP Jason Somer sold 10,000 shares of the company's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $8.56, for a total transaction of $85,600.00. Following the transaction, the executive vice president now owns 4,452 shares in the company, valued at approximately $38,109.12. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Inogen (NASDAQ:INGN) PT Raised to $7.00 at Stifel Nicolaus
Stifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)
Inogen (NASDAQ:INGN) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPS
Inogen (NASDAQ:INGN - Get Free Report) announced its quarterly earnings results on Tuesday. The medical technology company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.76) by $0.14. The business had revenue of $78.03 million for the quarter, compared to the consensus estimate of $73.67 million. Inogen had a negative return on equity of 38.98% and a negative net margin of 32.46%. The business's revenue was up 8.1% compared to the same quarter last year. During the same period last year, the business posted ($0.63) EPS.
Q1 2024 Inogen Inc Earnings Call
Inogen (NASDAQ:INGN) Price Target Raised to $7.00 at Stifel Nicolaus
Stifel Nicolaus upped their price target on shares of Inogen from $6.00 to $7.00 and gave the company a "hold" rating in a report on Wednesday.
Inogen's (INGN) Hold Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "hold" rating on shares of Inogen in a report on Wednesday.
Inogen: Q1 Earnings Snapshot
Inogen, Inc. (NASDAQ:INGN) Stock Position Lifted by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 347.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 265,485 shares of the medical technology company's stock after purchasing an additional 206,12
Inogen, Inc. (NASDAQ:INGN) Short Interest Update
Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 1,690,000 shares, a drop of 9.6% from the March 15th total of 1,870,000 shares. Based on an average daily trading volume, of 616,700 shares, the short-interest ratio is presently 2.7 days.
Inogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "hold" rating on shares of Inogen in a report on Tuesday.
INGN Apr 2024 10.000 call
INGN Apr 2024 5.000 put
INGN Apr 2024 15.000 call
INGN Apr 2024 12.500 call
INGN Apr 2024 7.500 put
Meros Investment Management LP Has $3.08 Million Holdings in Inogen, Inc. (NASDAQ:INGN)
Meros Investment Management LP lifted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 14.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 589,604 shares of the medical tech
Q1 2024 EPS Estimates for Inogen, Inc. (NASDAQ:INGN) Reduced by William Blair
Inogen, Inc. (NASDAQ:INGN - Free Report) - Investment analysts at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for shares of Inogen in a note issued to investors on Tuesday, February 27th. William Blair analyst M. Kaczor now expects that the medical technology company wi
Inogen Inc.
Why Is Inogen Stock Plummeting Today?
Acadian Asset Management LLC Raises Holdings in Inogen, Inc. (NASDAQ:INGN)
Acadian Asset Management LLC grew its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 195.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 389,792 shares of the medical technology c
What Wall Street expects from Inogen's earnings
Inogen Stock (NASDAQ:INGN), Short Interest Report
INGN Mar 2024 10.000 put
Tocqueville Asset Management L.P. Cuts Position in Inogen, Inc. (NASDAQ:INGN)
Tocqueville Asset Management L.P. lessened its stake in Inogen, Inc. (NASDAQ:INGN - Free Report) by 69.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,850 shares of the medical technology company's stock afte
Inogen (NASDAQ:INGN) Lifted to Outperform at William Blair
William Blair raised shares of Inogen from a "market perform" rating to an "outperform" rating in a research report on Thursday.
Inogen, Inc. (NASDAQ:INGN) Short Interest Up 22.1% in January
Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,880,000 shares, an increase of 22.1% from the January 15th total of 1,540,000 shares. Based on an average trading volume of 498,300 shares, the short-interest ratio is currently 3.8 days.
Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

41 banks launch ‘crypto dollar’ (Ad)

Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).

Here's how you capitalize (including #1 crypto to play it).

INGN Media Mentions By Week

INGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INGN
News Sentiment

0.32

0.42

Average
Medical
News Sentiment

INGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INGN Articles
This Week

3

2

INGN Articles
Average Week

Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:INGN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners